Renbo Qiu - Huadong Medicine CFO Department
| 000963 Stock | 36.05 0.54 1.52% |
CFO
Renbo Qiu is CFO Department of Huadong Medicine Co
| Age | 42 |
| Address | No. 866 Moganshan Road, Hangzhou, China, 310011 |
| Phone | 86 571 8990 3388 |
| Web | https://www.eastchinapharm.com |
Huadong Medicine Management Efficiency
The company has return on total asset (ROA) of 0.0671 % which means that it generated a profit of $0.0671 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.1478 %, meaning that it generated $0.1478 on every $100 dollars invested by stockholders. Huadong Medicine's management efficiency ratios could be used to measure how well Huadong Medicine manages its routine affairs as well as how well it operates its assets and liabilities. At present, Huadong Medicine's Total Assets are projected to increase significantly based on the last few years of reporting. The current year's Other Assets is expected to grow to about 1.3 B, whereas Other Current Assets are forecasted to decline to about 56.9 M.Similar Executives
| Found 3 records | CFO Age | ||
| Yan Jiang | Kweichow Moutai Co | 46 | |
| Jiawen Peng | China Merchants Bank | 55 | |
| Hua Wang | PetroChina Co Ltd | 49 | |
Management Performance
| Return On Equity | 0.15 | ||||
| Return On Asset | 0.0671 |
Huadong Medicine Leadership Team
Elected by the shareholders, the Huadong Medicine's board of directors comprises two types of representatives: Huadong Medicine inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Huadong. The board's role is to monitor Huadong Medicine's management team and ensure that shareholders' interests are well served. Huadong Medicine's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Huadong Medicine's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Renbo Qiu, CFO Department | ||
| Shun Zhou, Deputy Mang | ||
| Liang Lv, Chairman GM | ||
| Bo Chen, Secretary Board | ||
| Hui Wu, Deputy Mang |
Huadong Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Huadong Medicine a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.15 | ||||
| Return On Asset | 0.0671 | ||||
| Profit Margin | 0.08 % | ||||
| Operating Margin | 0.11 % | ||||
| Current Valuation | 60.87 B | ||||
| Shares Outstanding | 1.75 B | ||||
| Shares Owned By Insiders | 58.08 % | ||||
| Shares Owned By Institutions | 9.87 % | ||||
| Price To Book | 2.87 X | ||||
| Price To Sales | 1.52 X |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Huadong Stock
Huadong Medicine financial ratios help investors to determine whether Huadong Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Huadong with respect to the benefits of owning Huadong Medicine security.